These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 6147754)

  • 21. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of Artemia ras p21.
    Gandarillas A; Renart J; Quintanilla M
    Mol Cell Biochem; 1992 May; 112(1):29-33. PubMed ID: 1513332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a Gly19-->Val mutant of ram p25, a low Mr GTP-binding protein: loss of GTP/GDP-binding activity in the mutated ram p25.
    Nagata K; Suzuki T; Okano Y; Hamaguchi M; Nozawa Y
    Biochem Biophys Res Commun; 1992 Nov; 189(1):330-5. PubMed ID: 1449488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-regulation of metastatic and transforming activity of normal and mutant ras genes.
    Egan SE; Broere JJ; Jarolim L; Wright JA; Greenberg AH
    Int J Cancer; 1989 Mar; 43(3):443-8. PubMed ID: 2784421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
    Schweins T; Geyer M; Kalbitzer HR; Wittinghofer A; Warshel A
    Biochemistry; 1996 Nov; 35(45):14225-31. PubMed ID: 8916907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional structure of p21 in the active conformation and analysis of an oncogenic mutant.
    Wittinghofer F; Krengel U; John J; Kabsch W; Pai EF
    Environ Health Perspect; 1991 Jun; 93():11-5. PubMed ID: 1773783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli.
    Manne V; Yamazaki S; Kung HF
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):6953-7. PubMed ID: 6438627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function.
    Srivastava SK; Lacal JC; Reynolds SH; Aaronson SA
    Mol Cell Biol; 1985 Nov; 5(11):3316-9. PubMed ID: 3915772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanosine triphosphatase stimulation of oncogenic Ras mutants.
    Ahmadian MR; Zor T; Vogt D; Kabsch W; Selinger Z; Wittinghofer A; Scheffzek K
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7065-70. PubMed ID: 10359839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and biological activities of N-ras proteins.
    Geis AM; Nicolson M; Goldman RA
    Biochem Biophys Res Commun; 1986 Sep; 139(2):771-9. PubMed ID: 3533068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivity of a sulfhydryl group of the ras oncogene product p21 modulated by GTP binding.
    Hattori S; Yamashita T; Copeland TD; Oroszlan S; Shih TY
    J Biol Chem; 1986 Nov; 261(31):14582-6. PubMed ID: 3533923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of GTP hydrolysis by p21N-ras catalyzed by GAP: studies with a fluorescent GTP analogue.
    Moore KJ; Webb MR; Eccleston JF
    Biochemistry; 1993 Jul; 32(29):7451-9. PubMed ID: 8338843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.
    Lacal JC; Santos E; Notario V; Barbacid M; Yamazaki S; Kung H; Seamans C; McAndrew S; Crowl R
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5305-9. PubMed ID: 6089191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.
    Kamata T; Feramisco JR
    Nature; 1984 Jul 12-18; 310(5973):147-50. PubMed ID: 6610834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning of bovine GAP and its interaction with oncogenic ras p21.
    Vogel US; Dixon RA; Schaber MD; Diehl RE; Marshall MS; Scolnick EM; Sigal IS; Gibbs JB
    Nature; 1988 Sep; 335(6185):90-3. PubMed ID: 2842690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides.
    Schmidt G; Lenzen C; Simon I; Deuter R; Cool RH; Goody RS; Wittinghofer A
    Oncogene; 1996 Jan; 12(1):87-96. PubMed ID: 8552403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product.
    Calés C; Hancock JF; Marshall CJ; Hall A
    Nature; 1988 Apr; 332(6164):548-51. PubMed ID: 2833702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.